The Hellenic experience regarding the efficacy of extracorporeal photopheresis (ECP) in the
treatment of 58 patients with chronic graft-versus-host disease (cGVHD) is presented in this …

Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity
after allogeneic stem cell transplantation. Though perfect response rates are not achieved …

Background Extracorporeal photopheresis (ECP) has been shown as active therapy for graft‐
versus‐host disease (GVHD). Study Design and Methods The aim was to ascertain the role …

Background and objectives Extracorporeal photopheresis (ECP) is a treatment strategy in
steroid-refractory chronic graft-versus-host disease (cGvHD). In this study, we aimed to …

The aim of our study was to assess the efficacy of extracorporeal photopheresis (ECP) in
chronic graft-versus-host disease (GVHD). Eleven patients with chronic cutaneous GVHD …

BACKGROUND Steroid‐refractory acute graft‐versus‐host disease (aGVHD) is a serious
complication after hematopoietic stem cell transplantation. The long‐term outcome of the …

Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …

Extracorporeal photochemotherapy (ECP) has been progressively introduced into the
treatment of both acute and chronic graft‐versus‐host disease (cGvHD) over the last …

Chronic graft-versus-host disease (cGVHD) is a major limitation of successful hematopoietic
cell transplantation. The safety and efficacy of extracorporeal photopheresis (ECP) for 12 to …

Extracorporeal photopheresis (ECP) has been established as an effective treatment
modality for patients with chronic extensive graft-versus host disease (GVHD). In the present …